A modest proposal for a new way forward for clinical research: Involve insurance companies

James H Clark; Jayant M Pinto; Robert M Naclerio

doi:10.1002/alr.22980

A modest proposal for a new way forward for clinical research: Involve insurance companies

Int Forum Allergy Rhinol. 2022 May;12(5):685-689. doi: 10.1002/alr.22980. Epub 2022 Feb 9.

Authors

James H Clark¹, Jayant M Pinto², Robert M Naclerio²

Affiliations

¹ Department of Otolaryngology-Head and Neck Surgery, The Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.
² Department of Surgery, Section of Otolaryngology-Head and Neck Surgery, The University of Chicago, Chicago, Illinois, USA.

Abstract

Is it time for medical insurance companies to organize and fund clinical research that evaluates the role of new treatments (drugs or device-based therapies) in the context of existing clinical paradigms for common diseases?

Keywords: biologics; chronic rhinosinusitis with nasal polyps; clinical research; insurance.

Publication types

Editorial

MeSH terms

Humans
Insurance*